Campaign for Sustainable Drug Pricing (Csrxp)
13 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Campaign for Sustainable Drug Pricing (Csrxp)
Federal lobbying records
Bills it lobbied on8 of 28
S 1040 Drug Competition Enhancement Act5 reports · On the floor calendarS 1097 Interagency Patent Coordination and Improvement Act of 20255 reports · On the floor calendarS 1041 Affordable Prescriptions for Patients Act5 reports · Passed one chamberS 1096 Preserve Access to Affordable Generics and Biosimilars Act5 reports · On the floor calendarS 229 DTC Act of 20255 reports · In committeeS 1095 Stop STALLING Act5 reports · On the floor calendarS 1533 A bill to amend title 38, United States Code, to make permanent and codify the pilot program for use of contract physicians for disability examinations, and for other purposes4 reports · Out of committeeHR 3010 No Handouts for Drug Advertisements Act4 reports · In committeeEvery link on this map
The same connections as a table, with the reason each one is here.
| S 1040 | Bills it lobbied on | Campaign for Sustainable Drug Pricing (Csrxp) named S 1040, “Drug Competition Enhancement Act”, in 5 lobbying reports. | 5 reports |
| S 1097 | Bills it lobbied on | Campaign for Sustainable Drug Pricing (Csrxp) named S 1097, “Interagency Patent Coordination and Improvement Act of 2025”, in 5 lobbying reports. | 5 reports |
| S 1041 | Bills it lobbied on | Campaign for Sustainable Drug Pricing (Csrxp) named S 1041, “Affordable Prescriptions for Patients Act”, in 5 lobbying reports. | 5 reports |
| S 1096 | Bills it lobbied on | Campaign for Sustainable Drug Pricing (Csrxp) named S 1096, “Preserve Access to Affordable Generics and Biosimilars Act”, in 5 lobbying reports. | 5 reports |
| S 229 | Bills it lobbied on | Campaign for Sustainable Drug Pricing (Csrxp) named S 229, “DTC Act of 2025”, in 5 lobbying reports. | 5 reports |
| S 1095 | Bills it lobbied on | Campaign for Sustainable Drug Pricing (Csrxp) named S 1095, “Stop STALLING Act”, in 5 lobbying reports. | 5 reports |
| S 1533 | Bills it lobbied on | Campaign for Sustainable Drug Pricing (Csrxp) named S 1533, “A bill to amend title 38, United States Code, to make permanent and codify the pilot program for use of contract physicians for disability examinations, and for other purposes”, in 4 lobbying reports. | 4 reports |
| HR 3010 | Bills it lobbied on | Campaign for Sustainable Drug Pricing (Csrxp) named HR 3010, “No Handouts for Drug Advertisements Act”, in 4 lobbying reports. | 4 reports |
| Amy Klobuchar | Lawmakers it funded or lobbied | Amy Klobuchar leads 2 bills Campaign for Sustainable Drug Pricing (Csrxp) lobbied on. | Leads 2 of these bills |
| John Cornyn | Lawmakers it funded or lobbied | John Cornyn leads 2 bills Campaign for Sustainable Drug Pricing (Csrxp) lobbied on. | Leads 2 of these bills |
| Richard Durbin | Lawmakers it funded or lobbied | Richard Durbin leads 2 bills Campaign for Sustainable Drug Pricing (Csrxp) lobbied on. | Leads 2 of these bills |
| Gregory Murphy | Lawmakers it funded or lobbied | Gregory Murphy leads 1 bill Campaign for Sustainable Drug Pricing (Csrxp) lobbied on. | Leads 1 of these bills |
| Jerry Moran | Lawmakers it funded or lobbied | Jerry Moran leads 1 bill Campaign for Sustainable Drug Pricing (Csrxp) lobbied on. | Leads 1 of these bills |